Application for May 2027 Exam Opens 14 Feb 2027
FBILM Fellowship Examination
The FBILM Fellowship Examination is the BILM assessment for doctors seeking Fellowship of the British Institute for Longevity Medicine. It is designed to assess advanced knowledge, clinical judgement and professional standards in longevity, preventive and regenerative medicine, and to recognise doctors who practise in this field to a high level of competence and integrity.



Overview
The FBILM examination is intended for UK GMC‑registered doctors who wish to demonstrate a rigorous level of expertise in longevity medicine. It reflects BILM’s role as a learned society and professional body committed to setting standards in the public interest.
The examination is mapped to BILM’s longevity medicine curriculum and to the clinical, ethical and governance expectations expected of a professional body in this field.
What the exam assesses
The examination is designed to assess whether candidates can:
Apply evidence‑based reasoning to longevity, preventive and regenerative medicine.
Select appropriate patients for interventions and recognise when treatment is not indicated.
Interpret biomarkers, investigations and risk profiles in context.
Prescribe and monitor interventions safely, including dosing, contraindications and follow‑up.
Communicate clearly, ethically and professionally with patients and colleagues.
Demonstrate sound judgement, clinical governance awareness and respect for regulatory boundaries.
The examination is mapped to BILM’s longevity medicine curriculum and to the clinical, ethical and governance expectations expected of a professional body in this field.
The FBILM exam is structured to test both theoretical knowledge and practical clinical application.
01
Part 1: Longevity Medicine Theory
This section tests underpinning knowledge in longevity medicine through a combination of: Single Best Answer questions and Extended Matching Questions. These generally consist of evidence interpretation and guideline application and ethical and governance scenarios relevant to practice.
02
Part 2: Applied clinical assessment
This section, again in SBA/MCQ format, assesses higher‑level application of knowledge in a clinical format, with scenarios that may include patient selection and suitability for intervention, the Interpretation of investigations and biomarkers, treatment planning and monitoring, contraindications, adverse effects and safety decisions and communication and explanation of risk and uncertainty.
*
Please note
The exact structure, timings and pass requirements can be tailored by BILM to reflect the final approved curriculum and standard setting process. There is no official BILM clinical revision course but external organisations may run them with no affiliation to BILM.
Curriculum coverage
The exam is based on the BILM curriculum and may cover areas such as:
Core principles of longevity medicine.
Preventive cardiometabolic medicine.
Biomarkers of ageing and risk stratification.
Nutrition, exercise, sleep and behavioural interventions.
Pharmacological and non‑pharmacological longevity interventions.
Regenerative medicine principles and emerging therapeutics.
Clinical governance, ethics, consent and professionalism.
Research literacy and critical appraisal.
The FBILM examination is open to: GMC‑registered doctors in good standing.
Candidates are encouraged to prepare in a structured way, combining clinical experience, evidence review and familiarity with BILM standards
BILM supports candidates with a range of exam preparation resources, including:
- Curriculum guide and reading list.
- Sample questions and exam blueprint.
- Longevity guideline summaries and evidence reviews.
- Webinar teaching and revision sessions.
- Journal articles and recommended reading from the British Journal of Longevity Medicine.
-
Evidence-based medicine and real-world evidnce
-
Ageing Biology and multi-omics
-
Clinical care for age-related conditions
-
Lifestyle and nutrition interventions
-
psychosocial determinants of health
-
digital health and Ai-assisted tools
-
Evidence-based medicine and real-world evidnce
-
Ageing Biology and multi-omics
-
Clinical care for age-related conditions
-
Lifestyle and nutrition interventions
-
psychosocial determinants of health
-
digital health and Ai-assisted tools
FBILM Exam?
FBILM is intended to signal that a doctor has achieved a recognised level of knowledge and professional competence in longevity medicine. It also reflects commitment to ethical practice, evidence‑based care and ongoing professional development. For patients, FBILM offers reassurance that their doctor is working within a recognised framework of standards. For clinicians, it provides professional recognition and a pathway into a growing medical discipline.
Frequently asked questions
What does FBILM stand for?
FBILM stands for Fellow of the British Institute for Longevity Medicine.
Who can sit the exam?
The exam is intended for GMC‑registered doctors and other eligible physicians who meet BILM’s entry requirements.
What qualification do I receive if I pass?
Successful candidates may use the post‑nominals FBILM and will be admitted as Fellows of BILM.
Does passing the exam mean I can practise longevity medicine?
The exam recognises knowledge and competence, but safe practice also requires ongoing CPD, adherence to guidelines and compliance with all applicable legal and regulatory requirements.
How often is the exam held?
Annually. Exam dates and application windows will be published on the BILM website.
What is the pass mark?
Pass standards are set through BILM’s standard setting process and may vary by sitting depending on the final approved format.
Will there be revision resources?
Yes. BILM aims to provide curriculum guidance, webinars, sample questions and recommended reading.
Can I re-sit if I am unsuccessful?
Yes. Re-sit policies will be set out in the examination regulations up to a maximum of 6 attempts.
Still want to learn more?
Get in touch to discuss opportunities or if you have any further questions
